D.1 Fee Schedule - Unit Price per Testing Specimen.xls
XLS spreadsheet 196 KB Posted
- Solicitation number
- 75H71021R00003
About this file
This solicitation requests proposals for referral clinical laboratory testing services. The Navajo Area Indian Health Service is seeking an offeror to provide laboratory testing for its medical facilities, as outlined in solicitation number 75H71021R00003. Services required include items such as SARS-CoV-2 and influenza testing, various blood panels and cultures, microbiology services, and other diagnostic tests. Proposals are due by the date specified in the solicitation. The resulting contract will have an initial base period and four one-year options to extend. Pricing must be provided using the itemized fee schedule included in the request for pricing terms.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| NAVAJO AREA INDIAN HEALTH SERVICES | |||||||
| REFERRAL CLINICAL LABORATORY TESTING SERVICES | |||||||
| ITEMIZED FEE SCHEDULE | |||||||
| Quantities are estimated and are included for the purpose of evaluating the total bottomline price for base and subsequent option periods to assist in price analysis and price reasonableness determination. Final maximum limitations for each base and subsequent periods may differ from the total offered prices. | |||||||
| Annual Estimate | Base Year | First Option Year | Second Option Year | Third Option Year | Fourth Option Year | ||
| 1 | SARS-CoV-2, NAA | 71385 | |||||
| 2 | RPR, Rfx Qn RPR/Confirm TP | 9006 | |||||
| 3 | Hemoglobin A1c | 8912 | |||||
| 4 | HIV Ag/Ab with Reflex | 5824 | |||||
| 5 | Urine Culture, Routine | 3712 | |||||
| 6 | Vitamin D, 25-Hydroxy | 3923 | |||||
| 7 | TSH | 3933 | |||||
| 8 | Albumin/Creatinine Ratio,Urine | 3076 | |||||
| 9 | LP+LDL Direct | 2669 | |||||
| 10 | HBsAg Screen | 2123 | |||||
| 11 | Chlamydia/GC Amplification | 1323 | |||||
| 12 | Blood Culture, Routine | 1657 | |||||
| 13 | Occult Blood, Fecal, IA | 1209 | |||||
| 14 | Thyroxine (T4) Free, Direct, S | 1601 | |||||
| 15 | Hep B Surface Ab | 1456 | |||||
| 16 | Vitamin B12 and Folate | 1548 | |||||
| 17 | Beta Strep Gp A Culture | 737 | |||||
| 18 | H. pylori Stool Ag, EIA | 1387 | |||||
| 19 | Vitamin B12 | 1145 | |||||
| 20 | Comp. Metabolic Panel (14) | 1804 | |||||
| 21 | Sensitivity Organism #1 | 428 | |||||
| 22 | MIC Organism #1 | 1421 | |||||
| 23 | Lipid Panel | 1280 | |||||
| 24 | Hep A Ab, Total | 905 | |||||
| 25 | HCV Antibody reflex to NAA | 899 | |||||
| 26 | HCV Antibody | 514 | |||||
| 27 | Rheumatoid Arthritis Factor | 734 | |||||
| 28 | TSH+Free T4 | 714 | |||||
| 29 | Hep B Core Ab, Tot | 821 | |||||
| 30 | Lead, Blood (Pediatric) | 593 | |||||
| 31 | Fe+TIBC+Fer | 667 | |||||
| 32 | Antinuclear Antibodies, IFA | 597 | |||||
| 33 | C-Reactive Protein, Quant | 814 | |||||
| 34 | Ferritin, Serum | 948 | |||||
| 35 | RPR Qn+TP Abs | 852 | |||||
| 36 | QFT-TB Plus (Client Incubated) | 724 | |||||
| 37 | Rubella Antibodies, IgG | 559 | |||||
| 38 | CCP Antibodies IgG/IgA | 555 | |||||
| 39 | 737588 9+Oxycodone+Crt-Unbund | 470 | |||||
| 40 | Protein Electro.,S | 540 | |||||
| 41 | Organism ID | 510 | |||||
| 42 | HCV Ab w/Rflx to Verification | 710 | |||||
| 43 | PTH, Intact | 640 | |||||
| 44 | Varicella-Zoster V Ab, IgG | 426 | |||||
| 45 | Iron and TIBC | 580 | |||||
| 46 | RNA, Real Time PCR (Non-Graph) | 509 | |||||
| 47 | Sedimentation Rate-Westergren | 562 | |||||
| 48 | Ct, Ng, Trich vag by NAA | 236 | |||||
| 49 | HAVIgM+HBcIgM+HBeAb+HBeAg+H... | 362 | |||||
| 50 | ANA w/Reflex if Positive | 339 | |||||
| 51 | Prolactin | 347 | |||||
| 52 | Opiates Confirmation, Urine | 344 | |||||
| 53 | 763824 12+Oxycodone+Crt-Unbund | 303 | |||||
| 54 | Levetiracetam (Keppra), S | 366 | |||||
| 55 | Prot+CreatU (Random) | 237 | |||||
| 56 | AFP, Serum, Tumor Marker | 368 | |||||
| 57 | Prostate-Specific Ag, Serum | 463 | |||||
| 58 | C-Peptide, Serum | 359 | |||||
| 59 | Tacrolimus (FK506), Blood | 380 | |||||
| 60 | RPR+Rh+ABO+Rub Ab+Ab Scr+HBsAg | 369 | |||||
| 61 | Protein Electro, Random Urine | 301 | |||||
| 62 | Hep A Ab, IgM | 210 | |||||
| 63 | CBC With Differential/Platelet | 509 | |||||
| 64 | Testosterone, Serum | 288 | |||||
| 65 | Helper T-Lymph-CD4 | 327 | |||||
| 66 | FSH, Serum | 295 | |||||
| 67 | Estradiol | 280 | |||||
| 68 | Measles/Mumps/Rubella Immunity | 213 | |||||
| 69 | CEA | 354 | |||||
| 70 | Cancer Antigen (CA) 125 | 317 | |||||
| 71 | Uric A+ANA+RA Qn+CRP+ASO | 217 | |||||
| 72 | AFP Tetra | 269 | |||||
| 73 | Tacrolimus by Immunoassay | 301 | |||||
| 74 | HCV Antibody | 175 | |||||
| 75 | Triiodothyronine (T3), Free | 153 | |||||
| 76 | PSA Total (Reflex To Free) | 250 | |||||
| 77 | Aerobic Bacterial Culture | 199 | |||||
| 78 | Antineutrophil Cytoplasmic Ab | 222 | |||||
| 79 | Hepatitis B Surf Ab Quant | 240 | |||||
| 80 | Methylmalonic Acid, Serum | 334 | |||||
| 81 | Ct/GC NAA, Pharyngeal | 186 | |||||
| 82 | HLA B 27 Disease Association | 241 | |||||
| 83 | Coccidioides Abs, IgG/IgM, EIA | 181 | |||||
| 84 | Hepatitis Panel (4) | 180 | |||||
| 85 | Complement C4, Serum | 218 | |||||
| 86 | Free K+L Lt Chains,Qn,S | 240 | |||||
| 87 | Complement C3, Serum | 212 | |||||
| 88 | Anti-dsDNA Antibodies | 175 | |||||
| 89 | Ova + Parasite Exam | 172 | |||||
| 90 | Hematopath Consultation, Smear | 249 | |||||
| 91 | HCV RNA NAA Qual rfx to Quant | 194 | |||||
| 92 | C4+C3 | 190 | |||||
| 93 | Ct/GC NAA, Rectal | 138 | |||||
| 94 | ANA Comprehensive Panel | 179 | |||||
| 95 | Actin (Smooth Muscle) Antibody | 209 | |||||
| 96 | Cannabinoid (GC/MS), Urine | 134 | |||||
| 97 | Mitochondrial (M2) Antibody | 186 | |||||
| 98 | HSV 1 and 2-Spec Ab, IgG w/Rfx | 141 | |||||
| 99 | Cannabinoid Confirmation, Ur | 171 | |||||
| 100 | Lipase | 128 | |||||
| 101 | HP5 | 139 | |||||
| 102 | GGT | 122 | |||||
| 103 | Intrinsic Factor Abs, Serum | 240 | |||||
| 104 | Triiodothyronine (T3) | 149 | |||||
| 105 | ANCA Panel | 112 | |||||
| 106 | Osmolality, Urine | 192 | |||||
| 107 | Luteinizing Hormone(LH), S | 129 | |||||
| 108 | Ca+PTH Intact | 57 | |||||
| 109 | Phosphatidylethanol (PEth) | 125 | |||||
| 110 | Viral Culture,Rapid,Influenza | 116 | |||||
| 111 | Amphetamines Confirmation, Ur | 135 | |||||
| 112 | HSV Culture and Typing | 118 | |||||
| 113 | C difficile Toxins A+B, EIA | 119 | |||||
| 114 | Magnesium | 146 | |||||
| 115 | Organism ID | 101 | |||||
| 116 | CD4/CD8 Ratio Profile | 135 | |||||
| 117 | E coli Shiga Toxin EIA | 74 | |||||
| 118 | Testosterone,Free and Total | 97 | |||||
| 119 | B-Type Natriuretic Peptide | 213 | |||||
| 120 | Antinuclear Antibodies Direct | 129 | |||||
| 121 | Thyroid Peroxidase (TPO) Ab | 105 | |||||
| 122 | L. pneumophila Serogp 1 Ur Ag | 206 | |||||
| 123 | Organism ID | 115 | |||||
| 124 | Measles Antibodies, IgG | 76 | |||||
| 125 | Sjogren's Ab, Anti-SS-A/-SS-B | 107 | |||||
| 126 | H. pylori, IgG Abs | 76 | |||||
| 127 | ABO Grouping and Rho(D) Typing | 128 | |||||
| 128 | Streptococcus pneumoniae Ag | 213 | |||||
| 129 | Trich vag by NAA | 233 | |||||
| 130 | Folate (Folic Acid), Serum | 107 | |||||
| 131 | FANA Staining Patterns | 100 | |||||
| 132 | Homocyst(e)ine | 151 | |||||
| 133 | Antibody Screen | 123 | |||||
| 134 | Progesterone | 85 | |||||
| 135 | ENA+DNA/DS+Antich+Centro+Jo... | 97 | |||||
| 136 | HAV/HBV (Profile VII) | 43 | |||||
| 137 | Calcium, Ionized, Serum | 66 | |||||
| 138 | Prenatal Profile I | 78 | |||||
| 139 | Tramadol (GC/MS), Urine | 86 | |||||
| 140 | Buprenorphine, Urine | 198 | |||||
| 141 | Stool Culture | 122 | |||||
| 142 | LDL Cholesterol (Direct) | 67 | |||||
| 143 | Cryoglobulin, Ql, Serum, Rflx | 61 | |||||
| 144 | H pylori, IgM, IgG, IgA Ab | 110 | |||||
| 145 | Allergens, Zone 16 | 40 | |||||
| 146 | Ceruloplasmin | 98 | |||||
| 147 | HCV RNA by PCR, Qn Rfx Geno | 70 | |||||
| 148 | Cortisol | 103 | |||||
| 149 | hCG,Beta Subunit, Qnt, Serum | 82 | |||||
| 150 | Albumin, Body Fluid | 63 | |||||
| 151 | Buprenorphine Confirm, Urine | 171 | |||||
| 152 | Immunoglobulins A/E/G/M, Serum | 89 | |||||
| 153 | Hepatic Function Panel (7) | 88 | |||||
| 154 | Vitamin B1 (Thiamine), Blood | 74 | |||||
| 155 | RNA Qualitative | 172 | |||||
| 156 | Alpha-1-Antitrypsin, Serum | 122 | |||||
| 157 | Prealbumin | 93 | |||||
| 158 | Allergens w/Total IgE Area 11 | 29 | |||||
| 159 | Osmolality | 99 | |||||
| 160 | B.pertussisB.parapertussis PCR | 30 | |||||
| 161 | Total Score, add three scores | 253 | |||||
| 162 | CA 19-9 | 110 | |||||
| 163 | Upper Respiratory Culture | 53 | |||||
| 164 | 733726 13+Oxycodone+Crt-Scr | 39 | |||||
| 165 | Oxycodone/Oxymorphone Confirm | 71 | |||||
| 166 | Panel 083955 | 173 | |||||
| 167 | HSV 1/2 PCR | 97 | |||||
| 168 | HCV Real-Time, PCR, Quant | 57 | |||||
| 169 | Amphetamine (GC/MS), Urine | 33 | |||||
| 170 | BK Quant PCR (Plasma/Serum) | 79 | |||||
| 171 | Celiac Disease Panel | 75 | |||||
| 172 | Thyroid Antibodies | 71 | |||||
| 173 | Thyroglobulin by IMA | 76 | |||||
| 174 | CMV Quant DNA PCR (Plasma) | 86 | |||||
| 175 | TgAb+Thyroglobulin,IMA or RIA | 66 | |||||
| 176 | Immunoglobulin G, Qn, Serum | 80 | |||||
| 177 | Allergen Profile, Basic Food | 30 | |||||
| 178 | Anaerobic and Aerobic Culture | 74 | |||||
| 179 | Hep B Core Ab, IgM | 51 | |||||
| 180 | DHEA-Sulfate | 52 | |||||
| 181 | Calcitriol(1,25 di-OH Vit D) | 82 | |||||
| 182 | Liver-Kidney Microsomal Ab | 91 | |||||
| 183 | Aldolase | 59 | |||||
| 184 | ACTH, Plasma | 67 | |||||
| 185 | Bile Acids | 62 | |||||
| 186 | Thyroid Stim Immunoglobulin | 74 | |||||
| 187 | SARS-CoV-2 Antibody, IgG | 173 | |||||
| 188 | FSH and LH | 38 | |||||
| 189 | NuSwab Vaginitis Plus (VG+) | 208 | |||||
| 190 | Concentration | 55 | |||||
| 191 | Strep Gp B NAA | 50 | |||||
| 192 | Mtb NAA+AFB Smear/Cult/ID/AST | 56 | |||||
| 193 | HCV RT-PCR, Quant (Non-Graph) | 44 | |||||
| 194 | Lipid Panel With LDL/HDL Ratio | 206 | |||||
| 195 | T4 and TSH | 11 | |||||
| 196 | Sensitivity Organism #2 | 26 | |||||
| 197 | Basic Metabolic Panel (8) | 136 | |||||
| 198 | Haptoglobin | 68 | |||||
| 199 | Prothrombin Time (PT) | 62 | |||||
| 200 | Viral Culture,Rapid,Lesion | 58 | |||||
| 201 | 17-OH Progesterone LCMS | 40 | |||||
| 202 | Influenza A and B, RT PCR | 31 | |||||
| 203 | DNA/DS+AMA+ASMA | 42 | |||||
| 204 | Opiates Confirmation, Urine | 32 | |||||
| 205 | Thyroid Panel | 38 | |||||
| 206 | Reticulocyte Count | 57 | |||||
| 207 | Allergens(20) | 26 | |||||
| 208 | Celiac Ab tTG DGP TIgA | 47 | |||||
| 209 | Lithium (Eskalith(R)), Serum | 52 | |||||
| 210 | Immunofixation, Serum | 60 | |||||
| 211 | Complement, Total (CH50) | 53 | |||||
| 212 | Renin Activity, Plasma | 60 | |||||
| 213 | Cyclosporine, Blood | 110 | |||||
| 214 | Erythropoietin (EPO), Serum | 55 | |||||
| 215 | t-Transglutaminase (tTG) IgA | 61 | |||||
| 216 | %fPSA Reflex | 45 | |||||
| 217 | Organism ID | 59 | |||||
| 218 | Valproic Acid (Depakote)(R),S | 35 | |||||
| 219 | Hepatitis C Genotype | 35 | |||||
| 220 | White Blood Cells (WBC), Stool | 47 | |||||
| 221 | MIC Organism #2 | 62 | |||||
| 222 | IGF-1 | 39 | |||||
| 223 | CA 27.29 | 62 | |||||
| 224 | Bile Acids, Fractionated LCMS | 47 | |||||
| 225 | Lamotrigine (Lamictal), Serum | 40 | |||||
| 226 | Thyrotropin Receptor Ab, Serum | 33 | |||||
| 227 | Angiotensin-Converting Enzyme | 38 | |||||
| 228 | Beta-2 Microglobulin, Serum | 40 | |||||
| 229 | Aldosterone LCMS, Serum | 57 | |||||
| 230 | Anticardiolip Ab, IgA/G/M, Qn | 30 | |||||
| 231 | Mononucleosis Test, Qual | 33 | |||||
| 232 | Immunoglobulin E, Total | 47 | |||||
| 233 | Strep Gp B Culture | 25 | |||||
| 234 | HCV Genotyping Non Reflex | 20 | |||||
| 235 | Immunoglobulins A/G/M, Qn, Ser | 23 | |||||
| 236 | Antistreptolysin O Ab | 27 | |||||
| 237 | Protein Elec + Interp, Serum | 38 | |||||
| 238 | HIV 1/2 Ab Differentiation | 36 | |||||
| 239 | Anaerobic/Aerobic/Gram Stain | 49 | |||||
| 240 | MaterniT21 PLUS Core+SCA | 76 | |||||
| 241 | HCV RNA by PCR, Qn Rfx Geno | 34 | |||||
| 242 | Ethanol, Blood | 40 | |||||
| 243 | HBcAb+HBsAb+HBsAg+HCVAb+... | 13 | |||||
| 244 | Fungus (Mycology) Culture | 47 | |||||
| 245 | PT and PTT | 38 | |||||
| 246 | Lupus Anticoagulant Comp | 29 | |||||
| 247 | Viral Culture, General | 41 | |||||
| 248 | Lupus Anticoagulant Reflex | 36 | |||||
| 249 | Giardia lamblia Ag, EIA | 28 | |||||
| 250 | HCV RNA NAA Qualitative | 33 | |||||
| 251 | Transferrin | 28 | |||||
| 252 | Phenobarbital, Serum | 28 | |||||
| 253 | C-Reactive Protein, Cardiac | 39 | |||||
| 254 | Sirolimus (Rapamune), Blood | 27 | |||||
| 255 | Susceptibility, Aer + Anaerob | 38 | |||||
| 256 | C3+C4+CompT | 15 | |||||
| 257 | Antiglomerular BM Ab | 37 | |||||
| 258 | Antiphospholipid Syndrome Comp | 35 | |||||
| 259 | Immunoglobulin A, Qn, Serum | 30 | |||||
| 260 | Insulin | 13 | |||||
| 261 | Concentration | 24 | |||||
| 262 | Factor V Leiden Mutation | 34 | |||||
| 263 | HCV RNA NAA Qualitative | 28 | |||||
| 264 | Thyroxine (T4) | 30 | |||||
| 265 | QuantiFERON-TB Gold Plus | 15 | |||||
| 266 | QuantiFERON-TB Gold Plus | 15 | |||||
| 267 | T pallidum Ab (FTA-Ab) | 27 | |||||
| 268 | Acid Fast Smear+Culture W/Rflx | 19 | |||||
| 269 | HBV Quant PCR Rfx to Genotype | 30 | |||||
| 270 | HSV, IgM I/II Combination | 25 | |||||
| 271 | Vitamin B6, Plasma | 39 | |||||
| 272 | pH, Body Fluid | 26 | |||||
| 273 | Sodium, Urine | 37 | |||||
| 274 | RSV Ag, EIA | 14 | |||||
| 275 | Calprotectin, Fecal | 44 | |||||
| 276 | Procalcitonin | 41 | |||||
| 277 | Comp panel: Leukemia/Lymphoma | 23 | |||||
| 278 | Flow Marker, First | 23 | |||||
| 279 | Flow Markers X 15 | 23 | |||||
| 280 | Flow Interp 16 or more | 23 | |||||
| 281 | VDRL, CSF | 40 | |||||
| 282 | Antiparietal Cell Antibody | 48 | |||||
| 283 | H pylori Breath Test | 37 | |||||
| 284 | MRSA Screening Culture | 22 | |||||
| 285 | Protein Total, Qn, 24-Hr Urine | 27 | |||||
| 286 | Ammonia, Plasma | 18 | |||||
| 287 | Testosterone, Free, Direct | 28 | |||||
| 288 | Alk Phos Isoenzyme | 12 | |||||
| 289 | Pap IG, HPV-hr | 24 | |||||
| 290 | EBV Acute Infection Antibodies | 6 | |||||
| 291 | Benzodiazepines Confirm, Urine | 17 | |||||
| 292 | Specific Gravity | 18 | |||||
| 293 | Varicella-Zoster Ab, IgM | 18 | |||||
| 294 | Tramadol, Urine | 15 | |||||
| 295 | HBV Vaccine Follow-Up (Pro XI) | 13 | |||||
| 296 | HLA B5701 Test | 13 | |||||
| 297 | AFP, Serum, Open Spina Bifida | 40 | |||||
| 298 | Zinc, Plasma or Serum | 57 | |||||
| 299 | Rocky Mtn Spotted Fev, IgG, Qn | 14 | |||||
| 300 | MaterniT21 Genome No Gender | 30 | |||||
| 301 | Flow Markers X 3 | 21 | |||||
| 302 | Flow Markers X 5 | 21 | |||||
| 303 | Tramadol Screen, Urine | 51 | |||||
| 304 | Drug Profile, Ur, 9 Drugs | 63 | |||||
| 305 | Uric Acid | 33 | |||||
| 306 | PSA Total+% Free | 22 | |||||
| 307 | Amylase | 15 | |||||
| 308 | Fecal Fat, Qualitative | 24 | |||||
| 309 | GAD-65 Autoantibody | 25 | |||||
| 310 | HSV 1 and 2 IgM Abs, Indirect | 13 | |||||
| 311 | Gram Stain w/Sputum Cult Rflx | 20 | |||||
| 312 | RNA, PCR (NonGraph) rfx/Geno | 21 | |||||
| 313 | Anti-HMGCR Autoantibodies | 7 | |||||
| 314 | Thyroglobulin Antibody | 20 | |||||
| 315 | HSV-2 IgG Supplemental Test | 22 | |||||
| 316 | Tricyclic Antidepressant Conf | 19 | |||||
| 317 | Phosphorus | 38 | |||||
| 318 | Antiextractable Nuclear Ag | 20 | |||||
| 319 | Immature Cells | 28 | |||||
| 320 | Antimyeloperoxidase (MPO) Abs | 32 | |||||
| 321 | Epstein-Barr DNA Quant, PCR | 29 | |||||
| 322 | Beta-2 Glycoprotein I Ab,G,A,M | 10 | |||||
| 323 | Sputum Culture | 18 | |||||
| 324 | Comprehensive Thyroglobulin | 22 | |||||
| 325 | Topiramate (Topamax), Serum | 21 | |||||
| 326 | Thyroid Panel With TSH | 30 | |||||
| 327 | Influenza A+B Ag, EIA | 19 | |||||
| 328 | Lyme Antibody/Line Blot Reflex | 16 | |||||
| 329 | AFP, Tumor Marker (Serial) | 34 | |||||
| 330 | G6PD,Qn,Bld and Red Cell Count | 27 | |||||
| 331 | Metanephrines, Frac., Pl. Free | 26 | |||||
| 332 | Protein C Deficiency Profile | 23 | |||||
| 333 | Coag Studies Interp Report | 23 | |||||
| 334 | Toxoplasma gondii Ab, IgG | 23 | |||||
| 335 | ANA w/Reflex | 32 | |||||
| 336 | Giardia/Cryptosporidium EIA | 17 | |||||
| 337 | Allergen Panel, Food-Berry | 10 | |||||
| 338 | Organism ID | 15 | |||||
| 339 | Androstenedione LCMS | 6 | |||||
| 340 | Cytomegalovirus (CMV) Ab, IgG | 27 | |||||
| 341 | Free K+L Lt Chains,Qn,Ur | 22 | |||||
| 342 | CMV PCR | 19 | |||||
| 343 | Cancer Antigen (CA) 15-3 | 31 | |||||
| 344 | Vitamin A, Serum | 14 | |||||
| 345 | Antiproteinase 3 (PR-3) Abs | 25 | |||||
| 346 | Renal Panel (10) | 19 | |||||
| 347 | BCR-ABL1, CML/ALL, PCR, Quant | 15 | |||||
| 348 | General Tox Profile, Ur, 15 | 76 | |||||
| 349 | IFE and PE, Serum | 25 | |||||
| 350 | von Willebrand Profile | 22 | |||||
| 351 | DHEA, Serum | 21 | |||||
| 352 | Protein S Panel | 23 | |||||
| 353 | Creat Clearance, Normalized | 19 | |||||
| 354 | 88305 Surg Path-1st Site | 16 | |||||
| 355 | Mono Qual W/Rflx Qn | 8 | |||||
| 356 | IgG, Subclasses(1-4) | 18 | |||||
| 357 | GenoSure PRIme(R) | 13 | |||||
| 358 | Calcium, 24Hr Urine | 15 | |||||
| 359 | Hep Be Ag | 17 | |||||
| 360 | Antithrombin Activity | 18 | |||||
| 361 | Benzodiazepine Confirmation,Ur | 22 | |||||
| 362 | IGF-BP3 | 12 | |||||
| 363 | Aerobe ID + Suscept | 18 | |||||
| 364 | Factor II, DNA Analysis | 22 | |||||
| 365 | Copper, Serum | 23 | |||||
| 366 | Fibrinogen Activity | 28 | |||||
| 367 | Cortisol, Urinary Free | 14 | |||||
| 368 | Lead, Blood (Adult) | 13 | |||||
| 369 | Rocky Mtn Spotted Fever, IgM | 10 | |||||
| 370 | Acetylcholine Receptor Ab, All | 19 | |||||
| 371 | Creatine Kinase,Total | 12 | |||||
| 372 | TgAb+Thyroglobulin,IMA or LCMS | 26 | |||||
| 373 | Saccharomyces cerevisiae Panel | 14 | |||||
| 374 | Beta-Hydroxybutyrate | 26 | |||||
| 375 | GenoSure PRIme(R) | 15 | |||||
| 376 | GenoSure PRIme(R) Interp | 15 | |||||
| 377 | Fentanyl, Urine | 32 | |||||
| 378 | Meconium Amphetamine Confirm. | 13 | |||||
| 379 | Renin Activity and Aldosterone | 8 | |||||
| 380 | RPR | 11 | |||||
| 381 | Anaerobic Culture | 16 | |||||
| 382 | Ethyl Glucuronide LC/MS/MS | 60 | |||||
| 383 | Metanephrines, Frac, Qn, 24-Hr | 14 | |||||
| 384 | Cytomegalovirus (CMV) Ab, IgM | 21 | |||||
| 385 | Cortisol - AM | 22 | |||||
| 386 | Antiscleroderma-70 Antibodies | 17 | |||||
| 387 | Toxoplasma Abs IgG/IgM | 15 | |||||
| 388 | EBV Antibody Profile | 29 | |||||
| 389 | JAK2 Mutation Analysis, Qual | 14 | |||||
| 390 | HCV FibroSure | 15 | |||||
| 391 | Fentanyl/Norfentanyl, Confirm | 14 | |||||
| 392 | Barbiturate Confirmation, Ur | 19 | |||||
| 393 | Pancreatic Elastase, Fecal | 12 | |||||
| 394 | Resp Virus Panel (RVP) PCR | 25 | |||||
| 395 | Albumin, Random Urine | 16 | |||||
| 396 | Count 15-20 cells, 2 Karyotype | 17 | |||||
| 397 | Mumps Antibodies, IgG | 19 | |||||
| 398 | Protein C-Functional | 13 | |||||
| 399 | PTHrP (PTH-Related Peptide) | 19 | |||||
| 400 | Class Description | 6 | |||||
| 401 | Hep Be Ab | 17 | |||||
| 402 | Triglycerides, Fluid | 10 | |||||
| 403 | Protein S-Functional | 11 | |||||
| 404 | Insulin and C-Peptide, Serum | 13 | |||||
| 405 | Allergens(7) | 8 | |||||
| 406 | Everolimus | 14 | |||||
| 407 | Meconium Carboxy-THC Confirm | 13 | |||||
| 408 | Creatinine, Urine | 24 | |||||
| 409 | Insulin Antibodies | 18 | |||||
| 410 | Celiac Disease Ab Screen w/Rfx | 15 | |||||
| 411 | RA+ANA+CRP | 2 | |||||
| 412 | Allergen Profile, Food-Fruit | 10 | |||||
| 413 | Meconium 9 Panel | 0 | |||||
| 414 | Sensitivity Organism #3 | 4 | |||||
| 415 | Copper, WB | 13 | |||||
| 416 | Gestational 2 hour GTT | 8 | |||||
| 417 | D-Dimer | 16 | |||||
| 418 | dRVVT Mix | 15 | |||||
| 419 | HSV Type 1-Specific Ab, IgG | 5 | |||||
| 420 | Thyroglobulin by RIA | 10 | |||||
| 421 | Genital Culture, Routine | 11 | |||||
| 422 | Allergen Profile, Shellfish | 3 | |||||
| 423 | Tramadol | 2 | |||||
| 424 | Parvovirus B19, Human, IgG/IgM | 14 | |||||
| 425 | Aspergillus Ab, Qn, DID | 12 | |||||
| 426 | MRSA by NAA | 14 | |||||
| 427 | Cryptococcus Antigen, Serum | 17 | |||||
| 428 | Oxcarbazepine (Trileptal),S | 12 | |||||
| 429 | Myositis Panel III | 9 | |||||
| 430 | LDH | 18 | |||||
| 431 | Digoxin, Serum | 10 | |||||
| 432 | VZV Real Time PCR | 8 | |||||
| 433 | Anti-Jo-1 | 7 | |||||
| 434 | Chloride, Urine | 12 | |||||
| 435 | Ab Scr+Antibody ID | 14 | |||||
| 436 | Hgb Frac. Profile | 5 | |||||
| 437 | Hered.Hemochromatosis, DNA | 9 | |||||
| 438 | Growth Hormone, Serum | 12 | |||||
| 439 | Antibody Identification | 11 | |||||
| 440 | Phenytoin (Dilantin), Serum | 10 | |||||
| 441 | Phenytoin, Free, Serum | 7 | |||||
| 442 | Ab Scr+Antibody ID | 14 | |||||
| 443 | Antibody Identification | 11 | |||||
| 444 | Mumps Antibodies, IgM | 4 | |||||
| 445 | Body Fluid Culture, Sterile | 15 | |||||
| 446 | Hantavirus Antibodies, ELISA | 7 | |||||
| 447 | Lactic Acid, Plasma | 3 | |||||
| 448 | Gram Stain | 11 | |||||
| 449 | Protein,Total,Urine | 21 | |||||
| 450 | Scleroderma Diagnostic Profile | 6 | |||||
| 451 | BK Quant PCR (Urine) | 13 | |||||
| 452 | RNA Qualitative | 9 | |||||
| 453 | Amino Acid Profile, Qn, Plasma | 17 | |||||
| 454 | Creatinine, 24-Hour Urine | 4 | |||||
| 455 | Protein Electro, 24-Hour Urine | 8 | |||||
| 456 | Tryptase | 15 | |||||
| 457 | Gastrin, Serum | 3 | |||||
| 458 | PTT, Activated | 7 | |||||
| 459 | MDMA Confirmation, Urine | 34 | |||||
| 460 | Lipoprotein (a) | 16 | |||||
| 461 | Lactoferrin, Fecal, Quant. | 9 | |||||
| 462 | Lyme, Total Ab Test/Reflex | 6 | |||||
| 463 | C difficile Toxin Gene NAA | 22 | |||||
| 464 | Diabetes Autoimmune Profile | 11 | |||||
| 465 | Eosinophil, Urine | 7 | |||||
| 466 | NuSwab Vaginitis (VG) | 16 | |||||
| 467 | Organism Identification, Yeast | 19 | |||||
| 468 | Thyroid Cascade Profile | 6 | |||||
| 469 | Chromosome, Blood, Routine | 10 | |||||
| 470 | Cannabinoid Confirmation, Ur | 30 | |||||
| 471 | Gabapentin (Neurontin), Serum | 5 | |||||
| 472 | Chromosome Blood Routine 88230 | 10 | |||||
| 473 | Organism ID | 12 | |||||
| 474 | Catecholamines,Ur.,Free,24 Hr | 7 | |||||
| 475 | Salmonella/Shigella Screen | 5 | |||||
| 476 | Antihistone Antibodies | 7 | |||||
| 477 | Troponin I | 8 | |||||
| 478 | Hgb Frac. w/o Solubility | 12 | |||||
| 479 | IFE and PE, Random Urine | 13 | |||||
| 480 | Immunofixation, Urine | 10 | |||||
| 481 | CMV Abs IgG/IgM | 10 | |||||
| 482 | Thiopurine Methyltransferase | 6 | |||||
| 483 | Alk Phosphatase, Bone Specific | 7 | |||||
| 484 | NASH FibroSure | 7 | |||||
| 485 | HBV Real-Time PCR, Quant | 7 | |||||
| 486 | Allergen Profile, Food-Basic | 13 | |||||
| 487 | Cocaine (GC/MS), Urine | 9 | |||||
| 488 | Immunoglobulin M, Qn, Serum | 10 | |||||
| 489 | Zonisamide(Zonegran), Serum | 5 | |||||
| 490 | Allergens, Perennial | 2 | |||||
| 491 | Ethylene Glycol, Serum | 21 | |||||
| 492 | Panel 083904 | 10 | |||||
| 493 | Chromogranin A | 5 | |||||
| 494 | IA-2 Autoantibodies | 7 | |||||
| 495 | Anticardiolipin Ab, IgA, Qn | 7 | |||||
| 496 | Pap Lb, HPV-hr | 0 | |||||
| 497 | Na U+Cl U+K U | 10 | |||||
| 498 | HCV RealTime Abbott | 0 | |||||
| 499 | HIV GenoSure(R) MG Interp | 8 | |||||
| 500 | HIV GenoSure(R) MG | 8 | |||||
| 501 | Myoglobin, Urine | 6 | |||||
| 502 | Estrogens, Total | 9 | |||||
| 503 | Lacosamide | 6 | |||||
| 504 | Carbamazepine(Tegretol),S | 8 | |||||
| 505 | Urine Cytology | 8 | |||||
| 506 | Methanol | 19 | |||||
| 507 | Sequential 1 | 3 | |||||
| 508 | Sex Horm Binding Glob, Serum | 7 | |||||
| 509 | Cryptosporidium EIA | 6 | |||||
| 510 | Drug Screen 10 w/Conf,Meconium | 11 | |||||
| 511 | T3 Uptake | 6 | |||||
| 512 | Iron | 5 | |||||
| 513 | LD Isoenzymes | 6 | |||||
| 514 | Zinc, Whole Blood | 8 | |||||
| 515 | Cystatin C | 7 | |||||
| 516 | Epstein-Barr Virus PCR | 6 | |||||
| 517 | Celiac Disease Comprehensive | 2 | |||||
| 518 | HCV NS5A Drug Resistance Assay | 2 | |||||
| 519 | Methadone (GC/MS), Urine | 5 | |||||
| 520 | Coombs', Direct | 11 | |||||
| 521 | Antithrombin III, Func/Immunol | 6 | |||||
| 522 | Uric A+RA Qn+CRP+ASO | 4 | |||||
| 523 | Vitamin E | 10 | |||||
| 524 | Toxoplasma gondii Ab,IgM | 5 | |||||
| 525 | Coccidioides CF Antibody | 7 | |||||
| 526 | Anticardiolipin Ab, IgG/M, Qn | 2 | |||||
| 527 | M genitalium NAA, Urine | 11 | |||||
| 528 | Bacterial Vaginosis, NAA | 16 | |||||
| 529 | CA 125, Serum (Serial) | 7 | |||||
| 530 | Islet Cell Dysfunction Group 1 | 9 | |||||
| 531 | Food Allergy Profile | 3 | |||||
| 532 | 726778 7+Alc-Unbund | 12 | |||||
| 533 | Ethyl Glucuronide, Urine | 18 | |||||
| 534 | Benzodiazepines, Urine | 7 | |||||
| 535 | Coccidioides Antibody Panel | 19 | |||||
| 536 | Creatine Kinase (CK), MB/Total | 0 | |||||
| 537 | Allergen Profile, Mold | 2 | |||||
| 538 | T pallidum Screening Cascade | 0 | |||||
| 539 | PE+Interp(Rfx IFE),S | 5 | |||||
| 540 | Measles Antibodies, IgM | 2 | |||||
| 541 | Antipancreatic Islet Cells | 9 | |||||
| 542 | Beta-2 Glycoprotein I Ab,G/M | 4 | |||||
| 543 | Bartonella Antibody Panel | 4 | |||||
| 544 | ANA Comprehensive Plus Profile | 10 | |||||
| 545 | Pneumocystis Smear, DFA | 4 | |||||
| 546 | GenoSure(R) MG | 6 | |||||
| 547 | F087-IgE Melon | 4 | |||||
| 548 | Mycophenolic Acid and Metabo. | 7 | |||||
| 549 | Organism ID | 10 | |||||
| 550 | MIC Organism #3 | 9 | |||||
| 551 | Urea Nitrogen, U | 8 | |||||
| 552 | Rivaroxaban | 3 | |||||
| 553 | Lyme (B. burgdorferi) PCR | 3 | |||||
| 554 | B pertussis IgG/M/A Ab | 6 | |||||
| 555 | HCV RNA (International Units) | 8 | |||||
| 556 | T020-IgE Mesquite | 6 | |||||
| 557 | Reducing Substance, Feces | 1 | |||||
| 558 | Cell Ct, Synovial w/Crystals | 4 | |||||
| 559 | Autoimmune Profile | 9 | |||||
| 560 | Carbon Monoxide, Blood | 7 | |||||
| 561 | Chlamydia trachomatis Culture | 0 | |||||
| 562 | EBV, Chronic/Active Infection | 0 | |||||
| 563 | Myoglobin, Serum | 3 | |||||
| 564 | Calcium, Random Urine | 6 | |||||
| 565 | Heavy Metals Profile I, Blood | 5 | |||||
| 566 | Hexagonal Phase Phospholipid | 3 | |||||
| 567 | PTT-LA Mix | 3 | |||||
| 568 | Inhibin A, Ultrasensitive | 6 | |||||
| 569 | Protein S-Antigen | 7 | |||||
| 570 | Anti-Centromere B Antibodies | 6 | |||||
| 571 | t-Transglutaminase (tTG) IgG | 5 | |||||
| 572 | NuSwab BV and Candida, NAA | 12 | |||||
| 573 | Myasthenia Gravis Evaluation | 4 | |||||
| 574 | Anti-Mullerian Hormone (AMH) | 6 | |||||
| 575 | Allergens w/Total IgE Area 12 | 8 | |||||
| 576 | Panel 604845 | 9 | |||||
| 577 | IgE Peanut Component Profile | 3 | |||||
| 578 | Cyclosporine, Blood | 1 | |||||
| 579 | 725788 7 Drug-Unbund | 11 | |||||
| 580 | Barbiturate (GC/MS), Urine | 6 | |||||
| 581 | Tramadol | 0 | |||||
| 582 | Drug Screen 9 w/Conf,Meconium | 12 | |||||
| 583 | Cannabinoid Confirmation, Ur | 12 | |||||
| 584 | Physician Read Pap | 2 | |||||
| 585 | Internal Sample ID error | 0 | |||||
| 586 | Organism ID | 10 | |||||
| 587 | Soluble Liver Ag (IgG Ab) | 10 | |||||
| 588 | ENA+DNA/DS+Sjogren's | 5 | |||||
| 589 | Protein C Antigen | 6 | |||||
| 590 | Treponema pallidum Antibodies | 6 | |||||
| 591 | Factor VIII Activity | 1 | |||||
| 592 | Enterovirus RT-PCR | 5 | |||||
| 593 | HCV Ab Verification | 5 | |||||
| 594 | Anti-DNA(SS)IgG, Ab, Qn | 5 | |||||
| 595 | Helicobacter pylori, IgM Ab | 3 | |||||
| 596 | B pertussis, Nasophar Culture | 1 | |||||
| 597 | Anaerobe Identification Only | 2 | |||||
| 598 | DHEA-S+TesD/T | 7 | |||||
| 599 | Catecholamine+VMA, 24-Hr Urine | 2 | |||||
| 600 | MuSK Abs, Serum | 8 | |||||
| 601 | Chromosome Microarray | 3 | |||||
| 602 | Sodium, 24 hr Urine | 2 | |||||
| 603 | Serum Integrated 1 | 1 | |||||
| 604 | Sequential 2 | 2 | |||||
| 605 | Hepatitis A Profile | 0 | |||||
| 606 | Anemia Profile A | 7 | |||||
| 607 | Vitamin B2, Whole Blood | 4 | |||||
| 608 | Heparin Induced Platelet | 4 | |||||
| 609 | Lyme, Line Blot, Serum | 6 | |||||
| 610 | Strongyloides IgG Antibody | 5 | |||||
| 611 | Histoplasma Abs, Qn, DID | 3 | |||||
| 612 | Chlamydia, Conjunctiva, NAA | 4 | |||||
| 613 | Pap Lb, rfx HPV ASCU | 1 | |||||
| 614 | MyoMarker 3 Plus Profile (RDL) | 15 | |||||
| 615 | RNA, Real Time PCR (Graph) | 3 | |||||
| 616 | F044-IgE Strawberry | 3 | |||||
| 617 | F210-IgE Pineapple | 2 | |||||
| 618 | W013-IgE Cocklebur | 3 | |||||
| 619 | IgE Food w/Component Reflex II | 5 | |||||
| 620 | Carnitine, Total and Free | 3 | |||||
| 621 | Coccidioides Antibody by CF | 14 | |||||
| 622 | One Specimen Identifier | 7 | |||||
| 623 | Inpatient | 10 | |||||
| 624 | Vitamin C | 0 | |||||
| 625 | Uric Acid, 24 hr Urine | 2 | |||||
| 626 | Oxalate, Quant, 24-Hour Urine | 2 | |||||
| 627 | NMO IgG Autoantibodies | 2 | |||||
| 628 | Pleural Fluid Cytology | 2 | |||||
| 629 | Serum Integrated 2 | 2 | |||||
| 630 | Rubella Antibodies, IgM | 4 | |||||
| 631 | EBV Ab VCA, IgM | 4 | |||||
| 632 | dRVVT Confirm | 3 | |||||
| 633 | EBV PCR Quant (Whole Blood) | 9 | |||||
| 634 | Inhibin B | 7 | |||||
| 635 | SARS-CoV-2 Antibodies | 10 | |||||
| 636 | Cryptococcus Antigen, CSF | 8 | |||||
| 637 | Cryptococcus Ag Titer, Serum | 5 | |||||
| 638 | Acid Fast Smear+Culture | 9 | |||||
| 639 | Aspergillus Ag, BAL/Serum | 8 | |||||
| 640 | HSV NAA | 6 | |||||
| 641 | Fungus Culture With Stain | 1 | |||||
| 642 | Pap IG, rfx HPV ASCU | 2 | |||||
| 643 | IGP, rfx Aptima HPV ASCU | 7 | |||||
| 644 | RubeoAB IgM+RubIgM | 3 | |||||
| 645 | Flow Markers X 10 | 2 | |||||
| 646 | MTHFR | 6 | |||||
| 647 | Anti-HMGCR Ab (RDL) | 11 | |||||
| 648 | Reflex to GenoSure(R) MG | 3 | |||||
| 649 | IgE Peanut w/Component Reflex | 6 | |||||
| 650 | Drug Screen 13 w/Conf, WB | 4 | |||||
| 651 | Organic Acid Analysis, Urine | 5 | |||||
| 652 | Opiates Confirmation, Urine | 13 | |||||
| 653 | Amphetamines (GC/MS), Urine | 13 | |||||
| 654 | 798002 Tramadol GC/MS, Urine | 0 | |||||
| 655 | RNA Polymerase III IgG Abs | 0 | |||||
| 656 | 88305 Surg Path-2nd Site | 1 | |||||
| 657 | Chromosome High Resolution | 5 | |||||
| 658 | additional High Resolution ... | 5 | |||||
| 659 | ALT (SGPT) | 4 | |||||
| 660 | IFE+Protein Electro, 24-Hr Ur | 4 | |||||
| 661 | hCG,Beta Subunit,Qual,Serum | 5 | |||||
| 662 | Calcitonin, Serum | 6 | |||||
| 663 | Cold Agglutinin Titer, Quant | 5 | |||||
| 664 | Methotrexate (MTX), Serum | 2 | |||||
| 665 | First Trimester Screen w/NT | 1 | |||||
| 666 | Glucose, Body Fluid | 6 | |||||
| 667 | Protein, Body Fluid | 6 | |||||
| 668 | CBC, Platelet, No Differential | 8 | |||||
| 669 | Chromosome RFX to Microarray | 4 | |||||
| 670 | Chromosome Microarray (CMA) | 4 | |||||
| 671 | Immune Complexes Profile | 2 | |||||
| 672 | Acylcarnitine Profile, Plasma | 4 | |||||
| 673 | Lysozyme, Serum | 1 | |||||
| 674 | Bullous Pemphigoid 180 and 230 | 0 | |||||
| 675 | Min Inhibitory Conc (1 Drug) | 4 | |||||
| 676 | CMV Quant DNA PCR (Urine) | 4 | |||||
| 677 | 17-Hydroxypregnenolone, MS | 1 | |||||
| 678 | Mycoplasma pneu. IgG/IgM Abs | 3 | |||||
| 679 | Endomysial Antibody IgA | 5 | |||||
| 680 | CALR+JAK2 E12-15+MPL | 1 | |||||
| 681 | Dexamethasone, Serum | 3 | |||||
| 682 | Prt C Activity (Chromogenic) | 1 | |||||
| 683 | Allergen Profile, Food-Citrus | 0 | |||||
| 684 | M003-IgE Aspergillus fumigatus | 0 | |||||
| 685 | F033-IgE Orange | 2 | |||||
| 686 | W016-IgE Rough Marshelder | 1 | |||||
| 687 | F084-IgE Kiwi Fruit | 2 | |||||
| 688 | Propoxyphene, Urine | 10 | |||||
| 689 | Oxycodone/Oxymorphone, Urine | 10 | |||||
| 690 | Uranium, Urine | 5 | |||||
| 691 | Drug Screen 5 w/Conf,Meconium | 1 | |||||
| 692 | 88304 Surgical Path-1st Site | 6 | |||||
| 693 | Tissue Culture | 3 | |||||
| 694 | Organism ID | 4 | |||||
| 695 | CK, Total+Isoenzymes, Serum | 3 | |||||
| 696 | 5-HIAA,Quant.,24 Hr Urine | 4 | |||||
| 697 | Rh Factor | 1 | |||||
| 698 | K (Kell) RBC Antigen Typing | 3 | |||||
| 699 | Amitriptyline (Elavil), Serum | 1 | |||||
| 700 | Heavy Metals Profile, Urine | 4 | |||||
| 701 | Miscellaneous Testing | 6 | |||||
| 702 | Cortisol (3 Specimens) | 3 | |||||
| 703 | Reverse T3, Serum | 1 | |||||
| 704 | Antiadrenal Antibodies, Quant | 1 | |||||
| 705 | Catecholamines, Plasma | 2 | |||||
| 706 | Myasthenia Gravis Full Panel | 3 | |||||
| 707 | Factor V Activity | 3 | |||||
| 708 | Alpha-1-Antitrypsin Phenotyp | 1 | |||||
| 709 | EBV Ab VCA, IgG | 4 | |||||
| 710 | Anti-DNase B Strep Antibodies | 1 | |||||
| 711 | HBV Core Ab, IgG/IgM Diff | 2 | |||||
| 712 | Fructosamine | 3 | |||||
| 713 | JAK2 Exons 12-15 | 5 | |||||
| 714 | Calculi, Urinary | 0 | |||||
| 715 | G6PD,Qn,Bld and Hgb | 4 | |||||
| 716 | Norovirus, RT-PCR | 0 | |||||
| 717 | West Nile Virus Antibody,Serum | 4 | |||||
| 718 | West Nile Virus Antibody, CSF | 3 | |||||
| 719 | Parvovirus B19 Quant PCR | 4 | |||||
| 720 | PSA, Ultrasensitive W/O Serial | 3 | |||||
| 721 | Gliadin IgG/IgA Ab Prof, EIA | 4 | |||||
| 722 | Coccidioides Abs, IgG/M | 0 | |||||
| 723 | Histoplasma Gal'mannan Ag Ur | 2 | |||||
| 724 | AFB ID by DNA Probe Rflx AST | 1 | |||||
| 725 | Change IG Pap to LB Pap | 1 | |||||
| 726 | CA 27.29 (Serial Monitor) | 2 | |||||
| 727 | JAK2 V617F Rfx CALR/E12-15/MPL | 1 | |||||
| 728 | Testosterone, Women/Child | 3 | |||||
| 729 | CBG with Free Cortisol | 3 | |||||
| 730 | Adalimumab+Ab | 4 | |||||
| 731 | HCV RNA (International Units) | 6 | |||||
| 732 | Allergen Profile, Vegetable II | 1 | |||||
| 733 | Allergen Profile, Vegetable I | 3 | |||||
| 734 | F001-IgE Egg White | 1 | |||||
| 735 | F344-IgE Sage, Salvia | 1 | |||||
| 736 | Allergen Pediatric 6 Yrs Plus | 0 | |||||
| 737 | Voriconazole, Serum/Plasma | 5 | |||||
| 738 | Phencyclidine (GC/MS), Urine | 4 | |||||
| 739 | Drug Profile 799015 | 7 | |||||
| 740 | Adenosine Deaminase,Pleural Fl | 2 | |||||
| 741 | Pregabalin, Urine | 2 | |||||
| 742 | dsDNA (nDNA) Scrn by Crithidia | 0 | |||||
| 743 | 88305 Surg Path-3rd Site | 1 | |||||
| 744 | Organism ID | 0 | |||||
| 745 | FISH Analyze 100-300 cells X3 | 3 | |||||
| 746 | Triglycerides | 0 | |||||
| 747 | Bilirubin, Total/Direct, Serum | 2 | |||||
| 748 | Phospholipids, Serum | 2 | |||||
| 749 | Immunoglobulin D, Quant, Serum | 3 | |||||
| 750 | Porphobilinogen, Qn, Random Ur | 3 | |||||
| 751 | C1 Esterase Inhibitor, Serum | 3 | |||||
| 752 | Crystal,Synovial/Joint Fl | 2 | |||||
| 753 | Anti-Smooth Muscle/Mitochond. | 2 | |||||
| 754 | Internal QC AFB Smear Pos | 7 | |||||
| 755 | AFB ID by DNA Probe Rflx AST | 5 | |||||
| 756 | Anal(Rectal) Cytology, LBP | 0 | |||||
| 757 | Smith Antibodies | 3 | |||||
| 758 | Citric Acid (Citrate), Urine | 2 | |||||
| 759 | Hgb+Hct | 0 | |||||
| 760 | Chromosome POC Rfx CMA | 3 | |||||
| 761 | Cocaine Metabolite Confirm,Ur | 1 | |||||
| 762 | Magnesium, RBC | 2 | |||||
| 763 | Cryptococcus Antibodies, Quant | 2 | |||||
| 764 | EBV Early Antigen Ab, IgG | 5 | |||||
| 765 | LD, Body Fluid | 7 | |||||
| 766 | Cortisol, AM/PM | 2 | |||||
| 767 | Antiphospholipid Syndrome | 1 | |||||
| 768 | Serotonin, Serum | 2 | |||||
| 769 | C1 Esterase Inhibitor, Func | 3 | |||||
| 770 | IFE, PE and FLC, Serum | 0 | |||||
| 771 | Creatine Kinase (CK), MB | 1 | |||||
| 772 | PE and FLC, Serum | 3 | |||||
| 773 | NMR LipoProfile+Lipids+Graph | 2 | |||||
| 774 | Calcium/Creatinine Ratio | 2 | |||||
| 775 | HSV and VZV PCR Panel | 5 | |||||
| 776 | Proinsulin | 1 | |||||
| 777 | Cortisol, ACTH Stimulation | 2 | |||||
| 778 | Anti-PLA2R | 3 | |||||
| 779 | Heparin Induced Platelet W/Rfx | 3 | |||||
| 780 | Anticardiolipin Ab, IgG, Qn | 4 | |||||
| 781 | Anticardiolipin Ab, IgM, Qn | 4 | |||||
| 782 | Helicobacter pylori, IgA | 3 | |||||
| 783 | Straight Inoculation, No Smear | 2 | |||||
| 784 | GI Profile, Stool, PCR | 3 | |||||
| 785 | HSV Culture Without Typing | 1 | |||||
| 786 | Fungus Culture W/Rfx Rapid ID | 2 | |||||
| 787 | Pap IG (Image Guided) | 2 | |||||
| 788 | BRCAssure Comprehensive Test | 1 | |||||
| 789 | Comprehensive BRCA1/2 Analysis | 1 | |||||
| 790 | LP+Chol/HDL Ratio | 4 | |||||
| 791 | Flow Markers X 4 | 0 | |||||
| 792 | MPL Mutation Analysis | 1 | |||||
| 793 | CALR Mutation Analysis | 1 | |||||
| 794 | Venous Thromb. Patients on VKA | 5 | |||||
| 795 | MPN w/Hypereosinophilia FISH | 3 | |||||
| 796 | Anti-RNA Polymerase III (RDL) | 7 | |||||
| 797 | RNA, PCR(NonGraph)rfx/GenoPRI | 6 | |||||
| 798 | HCV RNA (International Units) | 0 | |||||
| 799 | Reflex to GenoSure PRIme(R) | 6 | |||||
| 800 | Allergen Profile, Food-Grain | 0 | |||||
| 801 | F025-IgE Tomato | 1 | |||||
| 802 | G006-IgE Timothy Grass | 0 | |||||
| 803 | T070-IgE White Mulberry | 1 | |||||
| 804 | F049-IgE Apple | 1 | |||||
| 805 | IgE Food Basic w/Component Rfx | 3 | |||||
| 806 | K082-IgE Latex | 3 | |||||
| 807 | 794388 7 Drug-Bund | 1 | |||||
| 808 | LC-1 (Liver Cytosol Protein-1) | 3 | |||||
| 809 | Juniper Mix IgE | 1 | |||||
| 810 | Myositis Panel I | 4 | |||||
| 811 | Serial Monitoring | 1 | |||||
| 812 | Organism ID | 1 | |||||
| 813 | FISH DNA Probe X7 | 3 | |||||
| 814 | Glucose | 0 | |||||
| 815 | Protein, Total | 2 | |||||
| 816 | Carotene, Beta | 3 | |||||
| 817 | Thyroxine Binding Globulin | 6 | |||||
| 818 | Leukocyte Alkaline Phos Score | 0 | |||||
| 819 | Potassium, 24 hr Urine | 1 | |||||
| 820 | Copper, Urine | 1 | |||||
| 821 | E/e RBC Antigen Typing | 2 | |||||
| 822 | Rapid Plasma Reagin, Quant | 2 | |||||
| 823 | Cytomegalovirus (CMV) Culture | 2 | |||||
| 824 | Pinworm Prep - Enterobius | 0 | |||||
| 825 | T3Free | 4 | |||||
| 826 | ADH | 2 | |||||
| 827 | Oligoclonal Banding, Serum+CSF | 1 | |||||
| 828 | Amenorrhea Profile | 0 | |||||
| 829 | Prenat Infect Dis Ab, IgG, Qn | 1 | |||||
| 830 | Hepatitis Follow-Up (Prof II) | 1 | |||||
| 831 | Hepatitis B Virus (Profile VI) | 2 | |||||
| 832 | Vitamin B3 (Niacin+Metabolite) | 1 | |||||
| 833 | Thyroglobulin by LCMS | 1 | |||||
| 834 | Desmoglein 1 and 3 | 0 | |||||
| 835 | Testosterone, Free/Tot Equilib | 2 | |||||
| 836 | Chlamydia Antibodies, IgG | 2 | |||||
| 837 | Glom Filt Rate, Estimated | 1 | |||||
| 838 | Heparin Anti-Xa | 5 | |||||
| 839 | Activated Protein C Resistance | 2 | |||||
| 840 | Myeloperoxidase (MPO) | 3 | |||||
| 841 | DONOR ABO Group/Rho(D) Type | 0 | |||||
| 842 | SARS-CoV-2 | 2 | |||||
| 843 | MAG IgM Autoantibodies | 4 | |||||
| 844 | Propeptide Type I Collagen | 0 | |||||
| 845 | HCV Antibody RFX to Quant PCR | 3 | |||||
| 846 | Lyme, IgM, Early Test/Reflex | 2 | |||||
| 847 | HSV-2 Type Spec Ab, IgG w/Rflx | 1 | |||||
| 848 | tTG/DGP Screen | 1 | |||||
| 849 | Brucella Antibody IgG, EIA | 3 | |||||
| 850 | Brucella Antibody IgM, EIA | 1 | |||||
| 851 | Inflammatory Bowel Disease-IBD | 2 | |||||
| 852 | C albicans + C glabrata, NAA | 2 | |||||
| 853 | Campylobacter Culture | 0 | |||||
| 854 | O+P Exam, PVA Only | 1 | |||||
| 855 | Cryptosporidium/Isospora Smear | 1 | |||||
| 856 | Modified Hodge Test | 2 | |||||
| 857 | MTB-RIF NAA with AFB Culture | 0 | |||||
| 858 | Giardia, EIA, Ova/Parasite | 2 | |||||
| 859 | Antiphospholipid Antibody | 2 | |||||
| 860 | Lipoprotein Phenotyping | 1 | |||||
| 861 | Cholesterol, Fluid | 0 | |||||
| 862 | Folate, RBC | 3 | |||||
| 863 | TSH Rfx on Abnormal to Free T4 | 4 | |||||
| 864 | PSA (Reflex To Free) (Serial) | 2 | |||||
| 865 | Lupus Anticoagulant Panel | 0 | |||||
| 866 | 21-Hydroxylase Antibodies | 0 | |||||
| 867 | Growth Hormone Antibodies | 1 | |||||
| 868 | Salivary Cortisol,MS | 2 | |||||
| 869 | Factor VIII Antigen | 0 | |||||
| 870 | Venous Thrombosis Profile | 1 | |||||
| 871 | Free T4 by Dialysis/Mass Spec | 3 | |||||
| 872 | Adalimumab+Ab (Serial Monitor) | 1 | |||||
| 873 | ZNT8 Antibodies | 1 | |||||
| 874 | HPV, high-risk | 0 | |||||
| 875 | Fragile X, PCR and Southern | 2 | |||||
| 876 | Fragile X, PCR reflex Southern | 1 | |||||
| 877 | Anti-U1 RNP Ab (RDL) | 6 | |||||
| 878 | ANA Titer and Pattern | 5 | |||||
| 879 | MyoMarker 3 Profile (RDL) | 5 | |||||
| 880 | Allergen Profile, Food-Fish | 1 | |||||
| 881 | E005-IgE Dog Dander | 0 | |||||
| 882 | F203-IgE Pistachio Nut | 2 | |||||
| 883 | F075-IgE Egg (Yolk) | 0 | |||||
| 884 | G008-IgE Bluegrass, Kentucky | 1 | |||||
| 885 | F009-IgE Rice | 2 | |||||
| 886 | W011-IgE Thistle, Russian | 0 | |||||
| 887 | T014-IgE Cottonwood | 0 | |||||
| 888 | W010-IgE Lamb's Quarters | 2 | |||||
| 889 | F259-IgE Grape | 1 | |||||
| 890 | Panel 603848 | 1 | |||||
| 891 | Allergens w/Comp Rflx Area 11 | 5 | |||||
| 892 | Hypersensitivity Pneumonitis | 2 | |||||
| 893 | Allergen Profile, Latex Plus | 1 | |||||
| 894 | Allergens, Zone 18 | 0 | |||||
| 895 | THC,MS,WB/SP RFX | 1 | |||||
| 896 | Opiates Conf (GC/MS) | 4 | |||||
| 897 | Propoxyphene (GC/MS), Urine | 5 | |||||
| 898 | 738078 8+Oxycodone-Unbund | 0 | |||||
| 899 | Fentanyl and Analogues | 3 | |||||
| 900 | Francisella tularensis Abs | 0 | |||||
| 901 | Family Health Care Network | 4 | |||||
| 902 | Organism ID | 0 | |||||
| 903 | Organism ID | 2 | |||||
| 904 | Sensitivity Organism #4 | 0 | |||||
| 905 | Calcium | 0 | |||||
| 906 | Sodium | 1 | |||||
| 907 | Bilirubin, Direct | 0 | |||||
| 908 | Creatinine | 2 | |||||
| 909 | Glucose, Plasma | 3 | |||||
| 910 | Thyroxine (T4) Free, Direct, S | 0 | |||||
| 911 | Magnesium, Urine | 0 | |||||
| 912 | Vanillylmandelic Acid, 24-Hr U | 1 | |||||
| 913 | Pyruvic Acid, Blood | 3 | |||||
| 914 | Hgb Solubility | 0 | |||||
| 915 | Jka/Jkb RBC Antigen Typing | 2 | |||||
| 916 | RPR | 0 | |||||
| 917 | RPR, Quant. | 2 | |||||
| 918 | Amebiasis Antibodies | 2 | |||||
| 919 | Volatiles, Blood | 2 | |||||
| 920 | Nortriptyline (Aventyl), Serum | 0 | |||||
| 921 | Acetaminophen (Tylenol), S | 0 | |||||
| 922 | Methadone (Dolophine), Serum | 0 | |||||
| 923 | GC Culture Only | 0 | |||||
| 924 | Abdominal Fluid Cytology | 2 | |||||
| 925 | Potassium, Urine | 2 | |||||
| 926 | RMSF, IgG, IFA | 3 | |||||
| 927 | Thyroid Profile II | 0 | |||||
| 928 | Antidiuretic Hormone Profile | 1 | |||||
| 929 | Vancomycin Peak, Serum | 2 | |||||
| 930 | Phenytoin,Free and Total,Serum | 2 | |||||
| 931 | Free Valproic Acid (Depakote) | 2 | |||||
| 932 | Nicotine and Metabolite, Quant | 3 | |||||
| 933 | Opiate Confirmation, Urine | 1 | |||||
| 934 | Antiskin Autoantibodies, Quant | 0 | |||||
| 935 | AChR Binding Abs, Serum | 1 | |||||
| 936 | PTT-LA Incub Mix | 0 | |||||
| 937 | Platelet Antibody Profile | 3 | |||||
| 938 | Vitamin K1 | 0 | |||||
| 939 | Retinol binding Protein(RbP) | 0 | |||||
| 940 | Lp-PLA2 Activity | 2 | |||||
| 941 | Bartonella DNA PCR | 0 | |||||
| 942 | JC Virus DNA,PCR (Whole Blood) | 0 | |||||
| 943 | Respiratory Profile, PCR | 3 | |||||
| 944 | Alpha Subunit (Free) | 3 | |||||
| 945 | NT-proBNP | 2 | |||||
| 946 | Vitamin A and E | 2 | |||||
| 947 | Serotonin Release Assay | 1 | |||||
| 948 | Tetanus Antitoxoid IgG Ab | 1 | |||||
| 949 | Celiac HLA Rflx to Ab Combo | 1 | |||||
| 950 | HTLV-I/II Antibodies, Qual. | 2 | |||||
| 951 | vWF Activity | 1 | |||||
| 952 | Protein S, Free | 1 | |||||
| 953 | Febrile Antibody Profile | 0 | |||||
| 954 | Antinuclear Ab Reflex Cascade | 0 | |||||
| 955 | Celiac Disease HLA DQ Assoc. | 0 | |||||
| 956 | Result | 3 | |||||
| 957 | Lower Respiratory Culture | 3 | |||||
| 958 | Antifungal Suscep, Fluconazole | 2 | |||||
| 959 | BV+Ct/Ng/Tv NAA+Yeast Culture | 1 | |||||
| 960 | MAC Susceptibility Broth | 1 | |||||
| 961 | Org ID by Sequencing Rflx AST | 1 | |||||
| 962 | Cryptococcus Ag Titer, CSF | 3 | |||||
| 963 | Fungus (Mycology) Culture | 3 | |||||
| 964 | MTB NAA With AFB Culture | 0 | |||||
| 965 | MRSA MSSA Screening Culture | 0 | |||||
| 966 | Result | 0 | |||||
| 967 | Susceptibility, N. gonorrhoeae | 2 | |||||
| 968 | Histoplasma Gal'mannan Ag Ser | 0 | |||||
| 969 | C. trachomatis NAA, Confirm | 2 | |||||
| 970 | AFB ID by DNA Probe | 3 | |||||
| 971 | Mtb Susceptibility Broth | 0 | |||||
| 972 | Measles Only Viral Culture | 1 | |||||
| 973 | Virus, Respiratory Panel, DFA | 1 | |||||
| 974 | Strep Gp B NAA+Rflx | 0 | |||||
| 975 | Fungal ID by Molecular Methods | 0 | |||||
| 976 | Ct NAA, Pharyngeal | 0 | |||||
| 977 | PapIG, HPV, rfx 16/18 | 3 | |||||
| 978 | Bilirubin Fraction, Neonatal | 0 | |||||
| 979 | SLE Profile C | 0 | |||||
| 980 | LDL Cholesterol (Direct) | 1 | |||||
| 981 | ANA | 0 | |||||
| 982 | NAFLD Cascade | 1 | |||||
| 983 | MT21 PLUS Core+SCA, NO Gender | 4 | |||||
| 984 | T Cell Panel (gamma, beta) | 0 | |||||
| 985 | JAK2 V617F Qual, Rfx E12-15 | 1 | |||||
| 986 | DHEA-Sulfate, Serum | 1 | |||||
| 987 | Lupus Anticoag/Cardiolipin Ab | 2 | |||||
| 988 | OB Complications Profile | 2 | |||||
| 989 | Flow Cytometry PNH | 1 | |||||
| 990 | Luteinizing Hormone, Pediatric | 3 | |||||
| 991 | Apixaban Anti-Xa | 4 | |||||
| 992 | 5-HIAA, Plasma | 1 | |||||
| 993 | 21-Hydroxylase Antibodies | 2 | |||||
| 994 | HPV, low volume rfx | 0 | |||||
| 995 | HBV DNA RealTime Abbott | 2 | |||||
| 996 | IgE+Allergens(27) | 1 | |||||
| 997 | Allergen Profile, Food-Legume | 2 | |||||
| 998 | Allergen Profile, Food-Meat | 0 | |||||
| 999 | E001-IgE Cat Dander | 0 | |||||
| 1000 | M006-IgE Alternaria alternata | 0 | |||||
| 1001 | F202-IgE Cashew Nut | 3 | |||||
| 1002 | M002-IgE Cladosporium herbarum | 0 | |||||
| 1003 | F020-IgE Almond | 3 | |||||
| 1004 | T007-IgE Oak, White | 0 | |||||
| 1005 | F017-IgE Hazelnut (Filbert) | 3 | |||||
| 1006 | W014-IgE Pigweed, Common | 0 | |||||
| 1007 | F079-IgE Gluten | 0 | |||||
| 1008 | F083-IgE Chicken | 2 | |||||
| 1009 | M001-IgE Penicillium chrysogen | 0 | |||||
| 1010 | F040-IgE Tuna | 1 | |||||
| 1011 | F036-IgE Coconut | 0 | |||||
| 1012 | F031-IgE Carrot | 2 | |||||
| 1013 | T009-IgE Olive Tree | 0 | |||||
| 1014 | W006-IgE Mugwort | 0 | |||||
| 1015 | W009-IgE Plantain, English | 2 | |||||
| 1016 | M004-IgE Mucor racemosus | 2 | |||||
| 1017 | F329-IgE Watermelon | 0 | |||||
| 1018 | F091-IgE Mango | 0 | |||||
| 1019 | F096-IgE Avocado | 0 | |||||
| 1020 | F220-IgE Cinnamon | 0 | |||||
| 1021 | F221-IgE Coffee | 1 | |||||
| 1022 | F233-IgE Ovomucoid | 1 | |||||
| 1023 | F242-IgE Bing Cherry | 0 | |||||
| 1024 | M207-IgE Aspergillus niger | 1 | |||||
| 1025 | T015-IgE Ash, White | 2 | |||||
| 1026 | T016-IgE Pine, White | 0 | |||||
| 1027 | T003-IgE Common Silver Birch | 0 | |||||
| 1028 | W045-IgE Alfalfa | 0 | |||||
| 1029 | T045-IgE Elm Cedar | 0 | |||||
| 1030 | Panel 604726 | 1 | |||||
| 1031 | Panel 606578 | 4 | |||||
| 1032 | Panel 606648 | 4 | |||||
| 1033 | Allergen Profile, Mini-Panel | 1 | |||||
| 1034 | Allergen Pediatric 0 - 3 Years | 2 | |||||
| 1035 | OXYCODONES,MS,WB/SP RFX | 2 | |||||
| 1036 | Drug Screen 11 w/Conf, Serum | 0 | |||||
| 1037 | Drug Screen 13 w/Conf, Serum | 2 | |||||
| 1038 | Heavy Metals Profile II, Blood | 1 | |||||
| 1039 | Amiodarone (Cordarone(R)), S | 2 | |||||
| 1040 | D/L Methamphetamine | 3 | |||||
| 1041 | Meconium Cocaine Confirmation | 2 | |||||
| 1042 | Benzodiazepines Confirm, Urine | 4 | |||||
| 1043 | Monitor Drug Profile 10(MW) | 3 | |||||
| 1044 | Specific Gravity | 4 | |||||
| 1045 | Ketamine and Mtb. Qt, S/P | 0 | |||||
| 1046 | Drugs of Abuse Scr ONLY, 10,WB | 0 | |||||
| 1047 | Opiates Confirmation, Urine | 0 | |||||
| 1048 | Factor VII Activity | 1 | |||||
| 1049 | Anti-Myelin Assoc Glycop IgG | 1 | |||||
| 1050 | Adenosine Deaminase,Peritoneal | 2 | |||||
| 1051 | GM1 Antibody IgG, IgM | 0 | |||||
| 1052 | Flunitrazepam (Rohypnol), WB | 0 | |||||
| 1053 | Aripiprazole | 3 | |||||
| 1054 | Encephalitis CSF | 3 | |||||
| 1055 | Porphyr. Fractionation, Plasma | 4 | |||||
| 1056 | HSV 1/2 Ab IgG/IgM CSF | 2 | |||||
| 1057 | HSV Type 1 Ab IgG, CSF | 2 | |||||
| 1058 | HSV Type 2 Ab IgG, CSF | 2 | |||||
| 1059 | Reducing Substances - Fecal | 4 | |||||
| 1060 | 88305 Surg Path-4th Site | 1 | |||||
| 1061 | Spec-Stain,GRP I-Micro 1st | 0 | |||||
| 1062 | NMR LipoProfile+Lipids | 0 | |||||
| 1063 | Stone Analysis | 3 | |||||
| 1064 | Pass-through Handling Fee | 2 | |||||
| 1065 | FISH Inter Analysis 100-300x1 | 2 | |||||
| 1066 | Chromosomes Leuk/Lymph | 1 | |||||
| 1067 | Organism ID | 2 | |||||
| 1068 | Organism ID | 3 | |||||
| 1069 | MIC Organism #4 | 2 | |||||
| 1070 | IHC 1st AB Stain x1 GLBL | 2 | |||||
| 1071 | FISH DNA Probe X6 | 1 | |||||
| 1072 | IHC ea addl AB Stain x2 GLBL | 2 | |||||
| 1073 | Albumin | 0 | |||||
| 1074 | Bilirubin, Total | 0 | |||||
| 1075 | AST (SGOT) | 2 | |||||
| 1076 | IFE and PE, CSF | 2 | |||||
| 1077 | Vitamin C | 2 | |||||
| 1078 | Phosphorus, 24 hr Urine | 0 | |||||
| 1079 | Glucose, Quantitative, Urine | 1 | |||||
| 1080 | PE(Rfx IFE), Random Ur | 2 | |||||
| 1081 | Aldosterone, Urine | 0 | |||||
| 1082 | Aldosterone/Renin Ratio | 0 | |||||
| 1083 | FGF-23 | 1 | |||||
| 1084 | T4, TBG and T4-TBG Index | 0 | |||||
| 1085 | Prostatic Acid Phos, Serum | 0 | |||||
| 1086 | Path Review, Per Protocol | 0 | |||||
| 1087 | HB Solu + Rflx Frac | 0 | |||||
| 1088 | S/s RBC Antigen Typing | 1 | |||||
| 1089 | k (Cellano) RBC Antigen Typing | 0 | |||||
| 1090 | Anti-Complement+Anti-IgG | 2 | |||||
| 1091 | RPR, Quant | 0 | |||||
| 1092 | Drug Screen (Blood and Serum) | 0 | |||||
| 1093 | Arsenic Exposure Profile, Ur | 2 | |||||
| 1094 | Theophylline, Serum | 0 | |||||
| 1095 | Lead, Urine | 2 | |||||
| 1096 | Chlordiazepoxide, Serum | 0 | |||||
| 1097 | Mercury, Urine | 2 | |||||
| 1098 | Salicylate, Serum | 1 | |||||
| 1099 | Primidone (Mysoline(R)), Serum | 0 | |||||
| 1100 | Fungus Stain | 2 | |||||
| 1101 | Parasite Exam, Blood | 0 | |||||
| 1102 | Parasite ID, Worm | 0 | |||||
| 1103 | Ova + Parasite Exam, Urine | 0 | |||||
| 1104 | Sputum Cytology | 0 | |||||
| 1105 | Beta-2 Microglobulin, Urine | 0 | |||||
| 1106 | VIP, Plasma | 0 | |||||
| 1107 | IGF-1 with Z-Score | 0 | |||||
| 1108 | Uric Acid, Urine | 1 | |||||
| 1109 | pH, Urine | 2 | |||||
| 1110 | Phosphorus, Random Urine | 0 | |||||
| 1111 | Platelet Autoantibody Panel | 1 | |||||
| 1112 | Antithrombin Antigen | 0 | |||||
| 1113 | Thrombin Time | 0 | |||||
| 1114 | Bilirubin, Total, Neonatal | 0 | |||||
| 1115 | Q Fever Antibodies, IgG | 0 | |||||
| 1116 | Apolipoprotein A-1 | 1 | |||||
| 1117 | Cholinesterase, Serum and RBC | 1 | |||||
| 1118 | Lead Standard Profile, Blood | 2 | |||||
| 1119 | Chromosome, Biopsies, POC/Skin | 0 | |||||
| 1120 | Chromosome, High Resolution | 1 | |||||
| 1121 | Systemic Lupus Profile A | 0 | |||||
| 1122 | Seasonal Allrgns, Fall--Weed | 0 | |||||
| 1123 | Seasonal Allrgns, Spring--Tree | 0 | |||||
| 1124 | C002-IgE Penicillin V | 1 | |||||
| 1125 | Leflunomide Metabolite (ARAVA) | 0 | |||||
| 1126 | Iodine, Serum or Plasma | 1 | |||||
| 1127 | Buprenorphine and Metabolite | 0 | |||||
| 1128 | Carbamazepine, Free, Serum | 2 | |||||
| 1129 | Heavy Metals Profile II, Urine | 2 | |||||
| 1130 | Phencyclidine, Confirm, Urine | 1 | |||||
| 1131 | Creutzfeldt-Jakob Disease | 2 | |||||
| 1132 | Rabies Neut.Abs Titrat.(RFFIT) | 0 | |||||
| 1133 | Mercury, Blood | 0 | |||||
| 1134 | Legionella pneumophila DFA | 1 | |||||
| 1135 | Antimyocardial Antibodies, Qn | 1 | |||||
| 1136 | AChR Modulating Abs, Serum | 2 | |||||
| 1137 | Myasthenia Gravis Panel W/Rflx | 2 | |||||
| 1138 | Factor II Activity | 0 | |||||
| 1139 | von Willebrand Factor (vWF) Ag | 0 | |||||
| 1140 | Factor X Activity | 1 | |||||
| 1141 | Factor XI Activity | 0 | |||||
| 1142 | Factor XII Activity | 0 | |||||
| 1143 | Factor XIII | 0 | |||||
| 1144 | Min Inhibitory Conc (2 Drugs) | 0 | |||||
| 1145 | Amylase, Body Fluid | 2 | |||||
| 1146 | RSV Ab, Quant | 2 | |||||
| 1147 | EBV VCA/EA Ab, IgG | 2 | |||||
| 1148 | Influenza A/B Ab, Quant | 2 | |||||
| 1149 | Request Problem | 1 | |||||
| 1150 | Platelet Count on Citrated Bld | 2 | |||||
| 1151 | FDP, Plasma | 0 | |||||
| 1152 | Fibrinogen Antigen | 1 | |||||
| 1153 | Thrombotic Risk Profile II | 0 | |||||
| 1154 | F-VIII INH, Comprehensive | 2 | |||||
| 1155 | Thrombotic Risk Profile I | 0 | |||||
| 1156 | Hexagonal Phase Phospholipid | 0 | |||||
| 1157 | ADAMTS13 Activity | 0 | |||||
| 1158 | dRVVT Confirm | 0 | |||||
| 1159 | Dilute Russell's Viper Venom | 0 | |||||
| 1160 | IFE+Kappa/Lambda Qn S | 1 | |||||
| 1161 | Alpha-1-Antitrypsin, Fecal, Qn | 0 | |||||
| 1162 | PE+Interp(Rfx IFE), 24-Hr U | 0 | |||||
| 1163 | PE (Rfx IFE+FLC), S | 1 | |||||
| 1164 | PE+Interp(Rfx IFE+FLC), S | 1 | |||||
| 1165 | Multiple Sclerosis(MS) Profile | 0 | |||||
| 1166 | PE (Rfx IFE), S | 1 | |||||
| 1167 | IgM Heavy Light Chains(HLC), S | 2 | |||||
| 1168 | Lipid Cascade w Graph | 1 | |||||
| 1169 | Blastomyces dermatitidis Abs | 0 | |||||
| 1170 | Ehrlichia Detection PCR | 0 | |||||
| 1171 | Mycoplasma pneumoniae, PCR | 2 | |||||
| 1172 | Human Herpes Virus 6 PCR | 1 | |||||
| 1173 | Toxoplasma gondii PCR | 0 | |||||
| 1174 | Histoplasma capsulatum Abs. | 0 | |||||
| 1175 | JC Virus DNA, PCR (CSF) | 2 | |||||
| 1176 | Plasmodium sp. PCR | 0 | |||||
| 1177 | DONOR ABO Group/Rho(D) Type | 0 | |||||
| 1178 | COVID-19, Flu A+B and RSV | 2 | |||||
| 1179 | GM1 IgM Autoantibodies | 1 | |||||
| 1180 | GM1 IgG Autoantibodies | 2 | |||||
| 1181 | Interleukin-6, Plasma | 1 | |||||
| 1182 | IGF-BP1 | 1 | |||||
| 1183 | N-Telopeptide, Serum | 1 | |||||
| 1184 | N-Telopeptide, Urine | 0 | |||||
| 1185 | AFP with AFP-L3% | 0 | |||||
| 1186 | Des gamma carboxy Prothrombin | 0 | |||||
| 1187 | HBsAb Quant HBIG Assessment | 1 | |||||
| 1188 | Histamine, Plasma | 2 | |||||
| 1189 | Free Androgen Index (FAI) | 1 | |||||
| 1190 | ENA+DNA/DS+Antich+Centro+FA... | 0 | |||||
| 1191 | Striation Abs, Serum | 0 | |||||
| 1192 | IgG, Subclass 4 | 1 | |||||
| 1193 | Complement C2 | 0 | |||||
| 1194 | Antigliadin Abs, IgG | 0 | |||||
| 1195 | T pallidum Immunoblot | 0 | |||||
| 1196 | Candida Antibodies IgG,IgA,IgM | 0 | |||||
| 1197 | Mycoplasma pneumoniae, IgM Ab | 0 | |||||
| 1198 | Tetanus/Diphtheria Ab | 1 | |||||
| 1199 | Panel 163550 | 0 | |||||
| 1200 | Celiac HLA Rflx to Abs | 1 | |||||
| 1201 | Celiac Ab tTG TIgA w/Rflx | 2 | |||||
| 1202 | Convalescent Plasma | 2 | |||||
| 1203 | Gluten Sensitivity Screen | 1 | |||||
| 1204 | HTLV-I/II Immunoblot | 1 | |||||
| 1205 | Antigliadin IgG (native) | 1 | |||||
| 1206 | F004-IgE Wheat | 1 | |||||
| 1207 | RA Expanded Profile | 1 | |||||
| 1208 | Celiac Ped Screen w Reflex | 1 | |||||
| 1209 | Immunoglobulin A, Qn, Serum | 1 | |||||
| 1210 | Ehrlichia Ab Panel | 0 | |||||
| 1211 | Apolipoprotein B | 2 | |||||
| 1212 | HLA Class 1,2 AbScr CL12RFX | 2 | |||||
| 1213 | Carbamazepine Sensitivity HLA | 2 | |||||
| 1214 | HLA Class I Antibody ID | 1 | |||||
| 1215 | NuSwab VG, Candida 6sp | 0 | |||||
| 1216 | Ct, Ng, Mycoplasmas NAA, Urine | 0 | |||||
| 1217 | NuSwab VG+, Candida 6sp | 1 | |||||
| 1218 | H. pylori Breath Test | 0 | |||||
| 1219 | O+P Exam, Formalin Only | 0 | |||||
| 1220 | Helicobacter pylori Culture | 0 | |||||
| 1221 | Occult Blood, Gastric Fluid | 2 | |||||
| 1222 | Dermatophyte Only, Culture | 0 | |||||
| 1223 | Vaginal Yeast Culture | 0 | |||||
| 1224 | BV+Yeast Culture | 1 | |||||
| 1225 | Antifungal Suscep,Ketoconazole | 2 | |||||
| 1226 | Yeast Only, Culture | 1 | |||||
| 1227 | Nocardia Susceptibility Broth | 1 | |||||
| 1228 | Rapid Grower Broth Suscep. | 0 | |||||
| 1229 | Slow Grower Broth Suscep. | 1 | |||||
| 1230 | Susceptibility, Haemophilus | 0 | |||||
| 1231 | MTB NAA Without AFB Culture | 1 | |||||
| 1232 | Cyclospora Smear, Stool | 0 | |||||
| 1233 | Bacterial Stool Pathogens, NAA | 0 | |||||
| 1234 | Organism ID by Sequencing | 0 | |||||
| 1235 | Anaerobic Bacteria, ID by Seq. | 0 | |||||
| 1236 | Internal QC AFB Smear Pos | 0 | |||||
| 1237 | Mtb AST Confirmation | 0 | |||||
| 1238 | Org ID by Sequencing Rflx AST | 1 | |||||
| 1239 | Strep Gp B Susceptibility | 1 | |||||
| 1240 | Virus, RSV Ag, DFA | 0 | |||||
| 1241 | IGP, Aptima HPV | 2 | |||||
| 1242 | RA Qn+SjoSSA+SjoSSB | 0 | |||||
| 1243 | Cockatiel Feathers, IgE | 0 | |||||
| 1244 | Prenat Infect Dis Ab, IgM, Qn | 1 | |||||
| 1245 | Lipid Panel w/ Chol/HDL Ratio | 1 | |||||
| 1246 | Varicella Zoster Abs, IgG/IgM | 0 | |||||
| 1247 | Aldosterone LCMS (2 Specimens) | 0 | |||||
| 1248 | HBV/HCV (Profile VIII) | 2 | |||||
| 1249 | Bili T+D (Neonatal) | 0 | |||||
| 1250 | Carmine Dye/Red Dye(Coch.)IgA | 0 | |||||
| 1251 | Rufinamide (Banzel) | 0 | |||||
| 1252 | Kidney Stone, Urine/Saturation | 0 | |||||
| 1253 | Catecholamines,Ur.,Free,Random | 0 | |||||
| 1254 | LP | 1 | |||||
| 1255 | Celiac Disease Antibody Screen | 1 | |||||
| 1256 | Inherited Thromb. of Pregnancy | 0 | |||||
| 1257 | ANA w/Reflex | 0 | |||||
| 1258 | ANA+ENA+RA Qn+DNA/DS+AMA+An... | 0 | |||||
| 1259 | Altria Studies Covance | 0 | |||||
| 1260 | Alpha-Galactosidase A | 2 | |||||
| 1261 | SMN1 Copy Number Analysis | 0 | |||||
| 1262 | MaterniT21 PLUS Core | 2 | |||||
| 1263 | MaterniT21 PLUS Core+ESS | 1 | |||||
| 1264 | hCG, Beta Subunit, Qn (Serial) | 0 | |||||
| 1265 | HHT Proband | 0 | |||||
| 1266 | Copy # of ENG & ACVR1 | 0 | |||||
| 1267 | Seq ENG | 0 | |||||
| 1268 | Seq ACVRL1 and or SMAD4 | 0 | |||||
| 1269 | ER/PR,Immunohistochem,Paraffin | 1 | |||||
| 1270 | Cystic Fibrosis Profile | 0 | |||||
| 1271 | T-Cell Gene Rearrangement, PCR | 1 | |||||
| 1272 | JAK2 V617F, Quantitative | 0 | |||||
| 1273 | VistaSeq HR Colorectal Cancer | 0 | |||||
| 1274 | HER-2 IHC With Reflex To FISH | 1 | |||||
| 1275 | CA 15-3 (Serial Monitor) | 1 | |||||
| 1276 | Immunohistochemical Stain(s) | 0 | |||||
| 1277 | BRCAssure Comprehensive Panel | 2 | |||||
| 1278 | ZAP-70 in B-CLL | 1 | |||||
| 1279 | Flow Markers X 2 | 0 | |||||
| 1280 | JAK2 Qt, Rfx CALR/E12-15/MPL | 0 | |||||
| 1281 | Factor IX Antigen | 0 | |||||
| 1282 | C-Telopeptide, Serum | 0 | |||||
| 1283 | Platelet Factor 4 | 2 | |||||
| 1284 | Dihydrotestosterone | 0 | |||||
| 1285 | Von Willebrand Factor Multi. | 1 | |||||
| 1286 | Macroprolactin | 2 | |||||
| 1287 | Free and Total Insulin | 0 | |||||
| 1288 | Salivary Cortisol X3, Timed | 1 | |||||
| 1289 | Positive PNH Billing | 1 | |||||
| 1290 | Negative PNH Billing | 0 | |||||
| 1291 | FSH, Pediatric | 2 | |||||
| 1292 | Infliximab (IFX) Conc+ IFX Ab | 2 | |||||
| 1293 | Factor V Leiden Reflex to R2 | 0 | |||||
| 1294 | Cortisol Dexamethasone Reflex | 1 | |||||
| 1295 | TPMT Genetic Test | 1 | |||||
| 1296 | ETA Conc+ETA Ab,Serial Monitor | 0 | |||||
| 1297 | T-Cell Activation, CD8 Subsets | 1 | |||||
| 1298 | HPV Genotype, 16/18 | 2 | |||||
| 1299 | cobas HPV, Rectal | 1 | |||||
| 1300 | CLL FISH Panel | 0 | |||||
| 1301 | FISH Oncology | 2 | |||||
| 1302 | FISH Microdeletion | 0 | |||||
| 1303 | APL(PML-RARA) Quant | 1 | |||||
| 1304 | Microarray | 1 | |||||
| 1305 | MDS FISH Panel | 0 | |||||
| 1306 | Cytochrome P450 2D6 Genotyping | 0 | |||||
| 1307 | MPN/CML FISH | 1 | |||||
| 1308 | POC Super Panel | 0 | |||||
| 1309 | PMS2 Comprehensive | 0 | |||||
| 1310 | Deletion/Duplication | 0 | |||||
| 1311 | Alpha-1-Antitrypsin Deficiency | 0 | |||||
| 1312 | Thrombotic Risk Panel, DNA | 0 | |||||
| 1313 | Anti-CCP Ab, IgG + IgA (RDL) | 1 | |||||
| 1314 | Anti-Sm Ab (RDL) | 1 | |||||
| 1315 | Anti-SRP Ab (RDL) | 2 | |||||
| 1316 | Anti-dsDNA Ab by Farr (RDL) | 2 | |||||
| 1317 | Anti-Nuclear Ab by IFA (RDL) | 2 | |||||
| 1318 | Scleroderma Comp Profile (RDL) | 2 | |||||
| 1319 | Arthritis Profile (RDL) | 2 | |||||
| 1320 | HCV RT-PCR, Quant (Graph) | 0 | |||||
| 1321 | HCV RNA (International Units) | 1 | |||||
| 1322 | Quant, RNA PCR | 0 | |||||
| 1323 | HCV NAA Qualitative (rfx Geno) | 0 | |||||
| 1324 | RealTime Abbott | 0 | |||||
| 1325 | HBV RT PCR, Quant (Graph) | 1 | |||||
| 1326 | HBV Quant rfx to Geno + DR | 2 | |||||
| 1327 | GenoSure Archive(R) | 0 | |||||
| 1328 | HIV GSArchive | 0 | |||||
| 1329 | HIV GSArchive Interp | 0 | |||||
| 1330 | GenoSure(R) Integrase | 0 | |||||
| 1331 | HIV GenoSure(R) Integrase | 0 | |||||
| 1332 | HIV GenoSure(R) Integrase I... | 0 | |||||
| 1333 | Allergen Profile, Food-Milk | 2 | |||||
| 1334 | F002-IgE Milk | 0 | |||||
| 1335 | F014-IgE Soybean | 0 | |||||
| 1336 | F004-IgE Wheat | 0 | |||||
| 1337 | W001-IgE Ragweed, Short | 0 | |||||
| 1338 | F201-IgE Pecan Nut | 2 | |||||
| 1339 | F024-IgE Shrimp | 1 | |||||
| 1340 | D002-IgE D farinae | 0 | |||||
| 1341 | T008-IgE Elm, American | 0 | |||||
| 1342 | I206-IgE Cockroach, American | 0 | |||||
| 1343 | F093-IgE Chocolate/Cacao | 0 | |||||
| 1344 | F023-IgE Crab | 1 | |||||
| 1345 | T010-IgE Walnut | 2 | |||||
| 1346 | F035-IgE Potato, White | 1 | |||||
| 1347 | G010-IgE Johnson Grass | 0 | |||||
| 1348 | F006-IgE Barley | 1 | |||||
| 1349 | F012-IgE Green Pea | 1 | |||||
| 1350 | F005-IgE Rye | 1 | |||||
| 1351 | F256-IgE Walnut | 2 | |||||
| 1352 | T218-IgE Oak, Live/Virginia | 0 | |||||
| 1353 | W002-IgE Ragweed, Western | 0 | |||||
| 1354 | F253-IgE Pine Nut, Pignoles | 0 | |||||
| 1355 | F007-IgE Oat | 1 | |||||
| 1356 | M014-IgE Epicoccum purpur | 2 | |||||
| 1357 | M009-IgE Fusarium proliferatum | 0 | |||||
| 1358 | Allergens w/Total IgE Area 1 | 0 | |||||
| 1359 | K082-IgE Latex | 0 | |||||
| 1360 | E003-IgE Horse Dander | 0 | |||||
| 1361 | E082-IgE Rabbit Epithelia | 2 | |||||
| 1362 | E214-IgE Feathers, Finch | 0 | |||||
| 1363 | E215-IgE Pigeon Feathers | 0 | |||||
| 1364 | F081-IgE Cheese, Cheddar Type | 1 | |||||
| 1365 | F082-IgE Cheese, Mold Type | 1 | |||||
| 1366 | F085-IgE Celery | 2 | |||||
| 1367 | F090-IgE Malt | 1 | |||||
| 1368 | F342-IgE Olive, Black | 0 | |||||
| 1369 | F211-IgE Blackberry | 0 | |||||
| 1370 | F232-IgE Ovalbumin | 1 | |||||
| 1371 | F219-IgE Fennel, Fresh | 1 | |||||
| 1372 | F284-IgE Turkey | 0 | |||||
| 1373 | F315-IgE Green Bean | 1 | |||||
| 1374 | G012-IgE Rye Grass | 0 | |||||
| 1375 | I070-IgE Fire Ant (Invicta) | 0 | |||||
| 1376 | I205-IgE Bumblebee | 0 | |||||
| 1377 | M012-IgE Aureobasidi pullulans | 0 | |||||
| 1378 | M046-IgE Bipolaris | 0 | |||||
| 1379 | T019-IgE Mimosa/Acacia | 0 | |||||
| 1380 | T011-IgE Maple Leaf Sycamore | 2 | |||||
| 1381 | W015-IgE Lenscale | 0 | |||||
| 1382 | W017-IgE Kochia | 0 | |||||
| 1383 | W023-IgE Dockweed, Yellow | 0 | |||||
| 1384 | Childhood Allergy Profile+IgE | 0 | |||||
| 1385 | IgE Food Prof w/Component Rflx | 1 | |||||
| 1386 | Panel 603851 | 0 | |||||
| 1387 | IgE Milk w/ Component Reflex | 0 | |||||
| 1388 | Panel 604239 | 0 | |||||
| 1389 | Panel 604350 | 0 | |||||
| 1390 | F340-IgE Carmine Red Dye | 0 | |||||
| 1391 | Panel 604721 | 1 | |||||
| 1392 | IgE Nut Prof. w/Component Rflx | 2 | |||||
| 1393 | Allergens (27) | 2 | |||||
| 1394 | Allergens w/Comp Rflx Area 12 | 1 | |||||
| 1395 | K080-IgE Formaldehyde | 0 | |||||
| 1396 | Allergens(35) | 0 | |||||
| 1397 | Hymenoptera Profile 2 | 2 | |||||
| 1398 | Disclaimer: | 0 | |||||
| 1399 | OPIATES,MS,WB/SP RFX | 2 | |||||
| 1400 | TRAMADOL,MS,WB/SP RFX | 2 | |||||
| 1401 | Drug Screen 8 w/Conf, WB | 0 | |||||
| 1402 | Drug Screen 7 w/Conf, WB | 1 | |||||
| 1403 | Drug Screen 16 w/Conf, WB | 1 | |||||
| 1404 | Methylmalonic Acid, Urine | 0 | |||||
| 1405 | Risperidone (Risperdal(R)), S | 2 | |||||
| 1406 | Eslicarbazepine Metabolite | 0 | |||||
| 1407 | 731612 9 Drug-Scr | 2 | |||||
| 1408 | 733690 12+Oxycodone+Crt-Scr | 0 | |||||
| 1409 | Oxycodone/Oxymorphone (GC/MS) | 2 | |||||
| 1410 | Amphetamine, Urine | 0 | |||||
| 1411 | Opiates, Urine | 1 | |||||
| 1412 | Nicotine Metabolite, Urine | 2 | |||||
| 1413 | 6-Acetylmorphine, Urine | 2 | |||||
| 1414 | 6-Acetylmorphine Confirm, Ur | 2 | |||||
| 1415 | GHB Screen, S/P | 0 | |||||
| 1416 | Buprenorphine, Urine | 0 | |||||
| 1417 | Fentanyl/Norfentanyl, Confirm | 2 | |||||
| 1418 | Mephedrone, MDPV, Methylone | 0 | |||||
| 1419 | Mescaline, Ur | 0 | |||||
| 1420 | Mescaline Confirmation | 0 | |||||
| 1421 | Ziprasidone | 1 | |||||
| 1422 | Clobazam (ONFI) | 2 | |||||
| 1423 | Drug Screen 5 w/Conf,Meconium | 0 | |||||
| 1424 | Methylphenidate + Mtb, Urine | 2 | |||||
| 1425 | Meconium Buprenorphine Confirm | 2 | |||||
| 1426 | Sinemet | 0 | |||||
| 1427 | MHPG 24 Hour Urine | 2 | |||||
| 1428 | Hydrocodone + Metabolites, U | 2 | |||||
| 1429 | Flucytosine, Serum/Plasma | 1 | |||||
| 1430 | Aspergillus versicolor IgE | 1 | |||||
| 1431 | Flunitrazepam (Rohypnol), S/P | 0 | |||||
| 1432 | Paraneoplastic Profile 1 | 1 | |||||
| 1433 | Anti-Myelin Assoc. Gly. IgM | 0 | |||||
| 1434 | Drug Screen 12 w/Conf,Meconium | 1 | |||||
| 1435 | Meconium Opiate Confirmation | 0 | |||||
| 1436 | Methamphetamine,Amphetamine | 1 | |||||
| 1437 | Drug Screen 11 w/Conf,Meconium | 2 | |||||
| 1438 | Zolpidem, WB | 0 | |||||
| 1439 | Sulfonylurea Screen QT, Ur | 0 | |||||
| 1440 | Paraneoplastic Autoanti. Eval | 2 | |||||
| 1441 | HIV-2 QPCR | 2 | |||||
| 1442 | CMV PCR Qual (fecal) | 0 | |||||
| 1443 | Hepatitis E Virus (HEV) IgM | 0 | |||||
| 1444 | N-methyl-D-Aspartate Recpt,CSF | 0 | |||||
| 1445 | MDA5 (CADM 140) | 0 | |||||
| 1446 | Anti-NXP-2 | 0 | |||||
| 1447 | Porphyrins, Profile | 2 | |||||
| 1448 | Porphyrins, Total Serum | 1 | |||||
| 1449 | Adenosine Deaminase, Serum | 0 | |||||
| 1450 | Toxocara Antibody | 0 | |||||
| 1451 | Pemphigus Antibody Panel | 0 | |||||
| 1452 | Coccidioides Abs Panel, CSF | 1 | |||||
| 1453 | Coccidioides Ab IgG ELISA, CSF | 0 | |||||
| 1454 | Coccidioides Ab IgM ELISA, CSF | 0 | |||||
| 1455 | Sus.Anti.Aero.Bact.Cust.MIC(1) | 0 | |||||
| 1456 | Fusarium Solani IgE | 0 | |||||
| 1457 | Kleihauer-Bet. Stain,Fetal Hgb | 0 | |||||
| 1458 | PBG Deaminase, Erythrocytes | 2 | |||||
| 1459 | Electrolytes, Fecal | 1 | |||||
| 1460 | Entamoeba Histolytica Ag, EIA | 0 | |||||
| 1461 | VZV Ab, IgG, CSF | 1 | |||||
| 1462 | Myositis Panel II | 0 | |||||
| 1463 | 88300 Surgical Pathology | 1 | |||||
| 1464 | 88304 Surgical Path-2nd Site | 0 | |||||
| 1465 | Decalcification, 1st | 2 | |||||
| 1466 | Spec-Stain,GRP I-Micro 2nd | 0 | |||||
| 1467 | Spec-Stain,GRP I-Micro 3rd | 0 | |||||
| 1468 | Spec-Stain,GRP II-All-Oth 1st | 0 | |||||
| 1469 | NTI Serum Gel Tube | 2 | |||||
| 1470 | NTI Stool | 2 | |||||
| 1471 | Mis-inventoried SIS | 0 | |||||
| 1472 | Send to PSC | 1 | |||||
| 1473 | FISH Probe 88271 X2 | 2 | |||||
| 1474 | FISH Probe 88271 X3 | 0 | |||||
| 1475 | Additional Cells Counted | 0 |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .